Core Scientific shares technical analysis: Seller pressure tests $16.55 support

Traders Union
All News
Stocks
Core Scientific drops 3.19% to $17.46

Highlights

DSC Meridian Capital LP acquired 1,905,252 shares of Core Scientific for approximately $48.76 million, indicating strong institutional activity.
Core Scientific reported a quarterly loss of $3.32 per share and revenue of $164.2 million, both falling short of estimates.
Shares of Core Scientific trade below key moving averages with bearish momentum, a 2 to 3 day range forecast of $16.55 to $18.37, and high likelihood of further downside.

Institutional buying rises as revenue and profits disappoint

DSC Meridian Capital LP recently acquired 1,905,252 shares of Core Scientific, Inc., representing an investment of approximately $48.76 million and reflecting sizable institutional activity. In the same period, Core Scientific reported a quarterly loss of ($3.32) per share, directly weighing on its earnings profile. Additionally, the company posted quarterly revenue of $164.2 million, falling short of estimates and highlighting near-term operational challenges.

Bearish momentum intensifies as key technical levels break

On the technical front, CORZ is trading below its MA-20 at $17.76 and MA-50 at $18.43 on the hourly chart, with the daily MA-200 set higher at $19.7. The Ichimoku Kijun is established at $18.2 as the immediate resistance level. Momentum remains subdued as MACD shows a strong sell signal, while ADX indicates a neutral trend environment. RSI registers at 40.83 and CCI maintains a sell bias; Stoch RSI is neutral. Bearish dominance is further highlighted by persistent negative readings from both Bull/Bear Power and the Awesome Oscillator.

Downside risk elevated as price faces narrow rebound window

Over the next 2–3 trading days, CORZ is expected to trade within a range of $16.55 to $18.37, reflecting a typical volatility band relative to current levels. The baseline scenario assumes continued sideways movement in this range, with a very high probability of further downside and a muted likelihood of a rebound. Should the price break above the $18.2 resistance, a recovery may develop; however, a breach below $16.55 would indicate renewed selling momentum.

Anton Kharitonov, analyst at Traders Union, sees persistent weakness in Core Scientific despite recent institutional inflow. He notes that poor earnings and missed revenue estimates continue to weigh down sentiment and fundamentals. Technically, ongoing bearish signals and failure to reclaim resistance underline a defensive stance. "Until CORZ regains strength above $18.2, downside risks remain my base case."

Previously it was reported that institutional accumulation supported a cautious but potentially consolidative outlook for Core Scientific shares amid mixed technical signals. The current environment reinforces this view, as persistent technical weakness and disappointing earnings keep the focus on the $18.2 resistance as a critical level for any potential recovery.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.